Healthcare associated infection: Novel strategies and antimicrobial implants to prevent surgical site infection

Annals of the Royal College of Surgeons of England

Volumn 92, Issue 6, 2010, Pages 453-458

  Leaper, David ^a   McBain, Andrew J ^b   Kramer, Axel ^c   Assadian, Ojan ^c   Sanchez, Jose Luis Alfonso ^d   Lumio, Jukka ^e   Kiernan, Martin ^f  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f Hospital Infection Society   (United Kingdom)

Author keywords

Antimicrobial sutures; Biofilms; Surgical site infection

Indexed keywords

ANTIINFECTIVE AGENT; TOPICAL ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTISEPSIS; BACTERIUM ADHERENCE; BIOFILM; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; HUMAN; INFECTION; METHODOLOGY; SURGICAL INFECTION; SUTURE;

ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTIC PROPHYLAXIS; ANTISEPSIS; BACTERIAL ADHESION; BIOFILMS; HUMANS; PROSTHESIS-RELATED INFECTIONS; SURGICAL WOUND INFECTION; SUTURES;

EID: 77957921675     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588410X12699663905276     Document Type: Review

References (51)

1. Department of Health. Winning Ways: working together to reduce health care associated infections in England. London: DH, 2003.
2. National Institute for Health and Clinical Excellence. Surgical site infection: prevention and treatment of surgical site infection. Clinical guideline 78. London: NICE, 2008.
3. Cruse PJ, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980; 60: 27-40.
4. Wilson AP, Webster A, Gruneberg RN, Treasure T, Sturridge MF. Repeatability of asepsis wound scoring method. Lancet 1986; i: 1208-9.
5. Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 1985; 121: 206-15.
6. Leaper DJ, Melling AG. Antibiotic prophylaxis in clean surgery: clean non-implant wounds. J Chemother 2001; 13 (Spec No 1): 96-101.
7. Melling AC, Leaper DJ. The impact of warming on pain and wound healing after hernia surgery: a preliminary study. J Wound Care 2006; 15: 104-8.
8. Mahoney CB, Odom J. Maintaining intraoperative normothermia: a meta-analysis of outcomes with costs. AANA J 1999; 67: 155-63.
9. Greif R, Akça O, Horn EP, Kurz A, Sessler DI. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med 2000; 342: 161-7. (Pubitemid 30051647)
10. Kabon B, Nagele A, Reddy D, Eagon C, Fleshman JW, Sessler DI et al. Obesity decreases perioperative tissue oxygenation. Anesthesiology 2004; 100: 274-80.
11. Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP et al. A surgicalsafety checklist to reduce morbidity and mortality in a global population. N Engl J Med 2009; 360: 491-9. The checklist can also be viewed at 〈http://www.who.int/patientsafety/safesurgery/en/〉.
12. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422-9.
13. Katz S, Izhar M, Mirelman D. Bacterial adherence to surgical sutures. A possible factor in suture induced infection. Ann Surg 1981; 194: 35-41.
14. Chu CC, Williams DF. Effects of physical configuration and chemical structure of suture materials on bacterial adhesion. A possible link to wound infection. Am J Surg 1984; 147: 197-204.
15. Suzuki T, Iihara H, Uno T, Hara Y, Ohkusu K, Hata H et al. Suture-related keratitis caused by Corynebacterium macginleyi. J Clin Microbiol 2007; 45: 3833-6.
16. Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000; 44: 1818-24.
17. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gammamediated macrophage killing. J Immunol 2005; 175: 7512-8.
18. Trautner BW, Darouiche RO, Catheter-associated infections: pathogenesis affects prevention.Arch Intern Med 2004; 164: 842-50.
19. Nucci C, Artini M, Pasmore M, Missiroli F, Costerton JW, Selan L. A microbiological and confocal microscopy study documenting a slime-producing Staphylococcus epidermidis isolated from a nylon corneal suture of a patient with antibiotic-resistant endophthalmitis. Graefes Arch Clin Exp Ophthalmol 2005; 243: 951-4.
20. Müller G, Kramer A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 2008; 61: 1281-7.
21. Calow T, Oberle K, Bruckner-Tuderman L, Jakob T, Schumann H. Contact dermatitis due to use of Octenisept(R) in wound care. J Dtsch Dermatol Ges 2009; 7: 759-65.
22. Sopata M, Ciupinska M, Glowacka A, Muszynski Z, Tomaszewska E. Effect of Octenisept antiseptic on bioburden of neoplastic ulcers in patients with advanced cancer. J Wound Care 2008; 17: 24-7.
23. Wiegand C, Abel M, Kramer A, Müller G, Ruth P, Hipler UC. Proliferationsförderung und Biokompatibilität von Polihexanid. GMS Krankenhaushyg Interdiszip 2007; 2: Doc43. Available from: 〈http://www. egms.de/en/journals/dgkh/2007-2/dgkh000076.shtml〉.
24. Kramer A, Roth B, Müller G. Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomised, stratified controlled, parallel-group study. Skin Pharmacol Physiol 2004; 17: 141-6.
25. Daeschlein G, Assadian O, Bruck JC, Meinl C, Kramer A, Koch S. Feasibility and clinical applicability of polihexanide for treatment of second-degree burn wounds. Skin Pharmacol Physiol 2007; 20: 292-6.
26. Blomstedt B, Osterberg B, Bergstrand A. Suture material and bacterial transport. An experimental study. Acta Chir Scand 1977; 143: 71-3.
27. Osterberg B, Blomstedt B. Effect of suture materials on bacterial survival in infected wounds. An experimental study. Acta Chir Scand 1979; 45: 431-4.
28. Chu CC, Williams DF. Effects of physical configuration and chemical structure of suture materials on bacterial adhesion. A possible link to wound infection. Am J Surg 1984; 147; 197-204.
29. Howe CW, Marston AT. A study on sources of postoperative staphylococcal infection. Surg Gynecol Obstet 1962; 115: 266-75.
30. Everett WG. Suture materials in general surgery. Prog Surg 1970; 8: 14-37.
31. Edlich RF, Panek PH, Rodeheaver GT, Turnbull VG, Kurtz LD, Edgerton MT. Physicaland chemical configuration of sutures in the development of surgical infection. Ann Surg 1973; 177: 679-88.
32. Smolianskaia AZ, Dronova OM, Zhukovskii VA. In vitro activity of surgical suture materials containing cephalosporin antibiotics. Antibiot Khimioter 1994; 39: 45-8.
33. Rodeheaver GT, Kurtz LD, Bellamy WT, Smith SL, Farris H, Edlich RF. Biocidal braidedsutures. Arch Surg 1983; 118: 322-7.
34. Polous IM, Goshchinskii VB, Grivenko SG, Belykh SI, Davydov AB, Bikaliuk IF. The validation of the use of iodine-containing suture thread in surgical practice. Klin Khir 1993; (1): 49-51.
35. Ming X, Nichols M, Rothenburger S. In vivo antibacterial efficacy of MONOCRYL plus antibacterial suture (Poliglecaprone 25 with triclosan). Surg Infect (Larchmt) 2007; 8: 209-14.
36. Storch ML, Rothenburger SJ, Jacinto G. Experimental efficacy study of coated Vicryl plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. SurgInfect (Larchmt) 2004; 5: 281-8.
37. Ming X, Rothenburger S, Nichols MM. In vivo and in vitro antibacterial efficacy of PDS plus (polydioxanone with triclosan) suture. Surg Infect (Larchmt) 2008; 9: 451-7.
38. Gilbert P, McBain AJ. Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with triclosan. Surg Infect (Larchmt)2002; 3 (Suppl 1): S55-63.
39. Barbolt TA. Chemistry and safety of triclosan, and its use as an antimicrobial coating on Coated Vicryl* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan). Surg Infect (Larchmt) 2002; 3 (Suppl 1): S45-53.
40. Aiello AE, Marshall B, Levy SB, Della-Latta P, Larson E. Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimicrob Agents Chemother 2004; 48: 2973-9.
41. United States Patent and Trademark Office (USPTO) Patent Application 20070010856, Antimicrobial sutures and methods of making them.
42. Rothenburger S, Spangler D, Bhende S, Burkley D. In vitro antimicrobial evaluation of Coated Vicryl* Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect (Larchmt) 2002; 3 (Suppl 1): S79-87.
43. Edmiston CE, Seabrook CR, Goheen MP, Krepel CJ, Johnson CP, Lewis BD et al. Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg 2006; 203: 481-9.
44. Deliaert AE, Van den Kerckhove E, Tuinder S, Fieuws S, Sawor JH, Meesters-Caberg MA et al. The effect of triclosan-coated sutures in wound healing. A double blind randomized prospective pilot study. J Plast Reconstr Aesthet Surg 2009; 62: 771-3.
45. Ford HR, Jones P, Gaines B, Reblock K, Simpkins DL. Intraoperative handling and wound healing: controlled clinical trial comparing coated Vicryl plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated Vicryl suture (coated polyglactin 910 suture). Surg Infect (Larchmt) 2005; 6: 313-21.
46. Pico RB, Jiménez LA, Sánchez MC, Castello CH, Bilbao AM, Arias MP et al. Prospective study comparing the incidence of wound infection following appendectomy for acute appendicitis in children: conventional treatment versus using reabsorbable antibacterial suture or gentamicin- impregnated collagen fleeces. Cir Pediatr 2008; 21: 199-202.
47. Marco F, Vallez R, Gonzalez P, Ortega L, de la Lama J, Lopez-Duran L. Study of the efficacy of coated Vicryl plus antibacterial suture in an animal model of orthopedic surgery. Surg Infect (Larchmt) 2007; 8: 359-65.
48. Rozzelle CJ, Leonardo J, Li V. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 2008; 2: 111-7.
49. Justinger C, Moussavian MR, Schlueter C, Kopp B, Kollmar O, Schilling MK. Antibiotic coating of abdominal closure sutures and wound infection. Surgery 2009; 145: 330-4.
50. Fleck T, Moidl R, Blacky A, Fleck M, Wolner E, Grabenwoger M et al. Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg 2007; 84: 232-6.
51. Alfonso JL, Pereperez SB, Canoves JM, Martinez MM, Martinez IM, Martin-Moreno JM. Are we really seeing the total costs of surgical site infections? A Spanish study. Wound Repair Regen 2007; 15: 474-81.